Oct. 14, 2020 – KITCHENER, ON — Cloud DX, a leading provider of telehealth and remote patient monitoring solutions, is pleased to announce the appointments of Stephanie Bird as the company’s new Chief Financial Officer (CFO) and Terry Finnigan as Cloud DX’s new head of manufacturing. The company is also today announcing the opening of a new 7,000-square-foot manufacturing facility located in Kitchener, Ont.
Senior executives join Cloud DX to spearhead growth
Joining Cloud DX as its newly appointed Chief Financial Officer, Stephanie Bird is a seasoned executive and CPA with more than 25 years' breadth of experience in finance, operations and risk management in fast-growing private and public companies. With proven expertise in building foundations for sustainable scalability, Stephanie has successfully led all aspects of multiple M&A transactions including fundraising and implementation of syndicated bank facilities over her career and served in senior executive roles with Just Energy, G Adventures and Kognitiv.
Joining Cloud DX as the company’s new head of manufacturing, Terry Finnigan brings decades of experience in launching products from new product innovation through to manufacturing honed within global brands such BlackBerry, Motorola and, most recently, technology scale-up Swift Labs. Terry will be responsible for the scale-up and growth of Cloud DX’s manufacturing operations, including manufacturing, quality control and supply chain resulting in timely delivery of the company’s ever-expanding product line including the Connected Health Kit and Pulsewave Health Monitor, and the VITALITI continuous health monitor.
New 7,000-square-foot manufacturing facility serves as the hub for Cloud DX product innovation
In response to growing customer demand for its Connected Health Kit, Cloud DX is also pleased today to announce the opening of a 7,000-square-foot manufacturing facility located in Kitchener, Ont. which will serve as the North American hub for product innovation, manufacturing and quality control. Unlike many of its competitors who rely on third-party technology, Cloud DX designs and manufactures its own proprietary diagnostic equipment, which allows the company to accelerate its innovation strategy, respond to shifting market demand and maintain the high-quality standards demanded by its clinical users.
Cloud DX continues strong growth and business momentum through 2020
In addition to the strategic appointments and news of its manufacturing expansion, Cloud DX is maintaining an aggressive growth trajectory through 2020. Highlights include:
- Five-fold growth in revenues since March 2020 reflecting the industry’s accelerated interest and adoption of virtual care and remote patient monitoring technologies
- Key projects and contracts including (McMaster Population Health Research Institute (PVC RAM), Vital Aire (COPD patient monitoring), Yukon Territory (palliative patient monitoring) and the Province of Alberta.
- $1.75M in funding from NGEN, $1.25M in funding from the Digital Supercluster in partnership with Curatio, and $300K in funding from NRC-IRAP
- U.S. launch of Connected Health Kit and rapid deployment quick start COVID-19 remote patient monitoring
- Cloud DX named one of Canada’s top 10 telehealth providers by Insightscare Magazine
- Cloud DX named Pandemic Tech Innovation Award Winner 2020 by TMC
“We are thrilled to have Stephanie and Terry join our leadership team as we begin to scale this business to meet exploding global demand for virtual care, accelerated by the COVID-19 pandemic,” says Cloud DX CEO Robert Kaul. “Their appointments and the opening of our manufacturing facility in Waterloo Region are simply the latest milestones in an incredible period of growth for Cloud DX. We are truly only just getting started.”
About Cloud DX
Cloud DX is a leader in digital healthcare with rapidly growing sales across North America. Our complete remote patient monitoring platform incorporates proprietary medical devices, mobile apps, clinical dashboards, artificial intelligence and EMR integration. In one recent third-party study, Cloud DX technology reduced hospital admissions due to COPD while achieving 100% patient satisfaction. The company is the co-winner of the Qualcomm Tricorder XPRIZE, a Fast Company “World Changing Idea” finalist and the recent winner of the Waterloo MedTech Startup to Scale Up Award of Excellence.
Social Links
Twitter: https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
For more information contact:
Ellyn Winters-Robinson
Ignition Communications (PR for Cloud DX)
519-574-2196
